Biden's Million Dollar Moonshot - $240 Million Is A Boon For Cancer Research, Will It Be a Boost For Pharma Stocks Too?

In September, Biden unveiled a $240 million investment to combat cancer, augmenting the administration's "Cancer Moonshot", an initiative with an array of new health resources. The funding, allocated

BenzingaDec 6, 2023 05:17

Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties

Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties

BenzingaDec 6, 2023 05:02

Analyst Expectations for Marinus Pharma's Future

Over the past 3 months, 5 analysts have published their opinion on Marinus Pharma (NASDAQ:MRNS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a

BenzingaDec 6, 2023 02:00

BridgeBio Pharma Submits NDA For Acoramidis To FDA For Treatment Of Transthyretin Amyloid Cardiomyopathy

BridgeBio Pharma Submits NDA For Acoramidis To FDA For Treatment Of Transthyretin Amyloid Cardiomyopathy

BenzingaDec 5, 2023 21:21

Marinus Pharma Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/05/2023 260% HC Wainwright & Co. → $27 Reiterates Buy → Buy 11/08/2023 233.33% Truist Securities $32 →

BenzingaDec 5, 2023 19:42

Fennec Pharma Announces Incremental $5M Investment From Petrichor, Original Deal Provided Access to up to $20M of Additional Financing

Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a commercial stage specialty pharmaceutical company focused on improving the lives of children with cancer, today announced the third closing of $5

BenzingaDec 5, 2023 18:58